Literature DB >> 2981081

Role of the liver in the degradation of lipoproteins.

A D Cooper.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2981081     DOI: 10.1016/s0016-5085(85)80155-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Scavenger functions of the liver endothelial cell.

Authors:  B Smedsrød; H Pertoft; S Gustafson; T C Laurent
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

2.  Receptor-mediated uptake of homologous low-density lipoproteins by isolated liver parenchymal cells of fetal rats.

Authors:  U Dürer; M Sommer; H Franke; B Schlag; R Dargel
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

3.  Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.

Authors:  Min-Rui Li; Sheng-Hong Zhang; Kang Chao; Xian-Hua Liao; Jia-Yan Yao; Min-Hu Chen; Bi-Hui Zhong
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome: lipoproteins in alcoholic hepatitis.

Authors:  Karan Mathur; Eduardo Vilar-Gomez; Margery A Connelly; Hanchang He; Arun J Sanyal; Naga Chalasani; Z Gordon Jiang
Journal:  J Clin Lipidol       Date:  2021-10-20       Impact factor: 4.766

5.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Influence of sodium monoketocholate on the hypolipidemic activity of lovastatin in healthy and diabetic rats.

Authors:  Suncica Kojic-Damjanov; Mirjana Djeric; Momir Mikov; Ksenija Kuhajda; Slavko Kevresan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Apr-Jun       Impact factor: 2.441

7.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Ali Hariri; Carol Nelson-Williams; Jia Nee Foo; Xian-Man Zhang; James Dziura; Richard P Lifton; Gerald I Shulman
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

8.  Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.

Authors:  Long Wang; Jinghui Guo; Jianping Lu
Journal:  Oncotarget       Date:  2016-06-14

Review 9.  Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.

Authors:  Xiao-Lin Li; Jian-Qing Sui; Lin-Lin Lu; Nan-Nan Zhang; Xin Xu; Quan-Yong Dong; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2016-03-10       Impact factor: 3.876

Review 10.  The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases.

Authors:  Nicholas W S Chew; Bryan Chong; Cheng Han Ng; Gwyneth Kong; Yip Han Chin; Wang Xiao; Mick Lee; Yock Young Dan; Mark D Muthiah; Roger Foo
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.